| CTRI Number |
CTRI/2020/03/023855 [Registered on: 09/03/2020] Trial Registered Prospectively |
| Last Modified On: |
06/03/2020 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison of oxygen delivery methods(nasal prongs and nasopharyngeal airway with t piece) for patients undergoing monitored anesthesia care in endoscopic procedures. |
|
Scientific Title of Study
|
Comparison of oxygen delivery methods for patient undergoing monitored anesthesia care in endoscopic procedures. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Birva Khara |
| Designation |
Associate professor |
| Affiliation |
Pramukh Swami medical college |
| Address |
Department of Anaesthesiology,
ShreeKrishna hospital,
Karamsad.
Gujarat NA Anand GUJARAT 388325 India |
| Phone |
9537122077 |
| Fax |
- |
| Email |
birvank@charutarhealth.org |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Birva Khara |
| Designation |
Associate professor |
| Affiliation |
Pramukh Swami medical college |
| Address |
Department of Anaesthesiology,
ShreeKrishna hospital,
Karamsad.
Gujarat NA Anand GUJARAT 388325 India |
| Phone |
9537122077 |
| Fax |
- |
| Email |
birvank@charutarhealth.org |
|
Details of Contact Person Public Query
|
| Name |
Dr Shivangi Agrawal |
| Designation |
PG Resident |
| Affiliation |
Pramukh Swami medical college |
| Address |
Department of Anaesthesiology,
ShreeKrishna hospital,
Karamsad.
Gujarat NA Anand GUJARAT 388325 India |
| Phone |
8980823635 |
| Fax |
- |
| Email |
shivangia410@gmail.com |
|
|
Source of Monetary or Material Support
|
| Shree Krishna Hospital Anand Sojitra Road Karamsad Gujarat |
|
|
Primary Sponsor
|
| Name |
Pramukhswami medical college |
| Address |
Shree Krishna Hospital
Karamsad
Gujarat |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Birva Khara |
Shree Krishna Hospital |
Shree Krishna Hospital, Anand Sojitra Road, Karamsad
Gujarat Anand GUJARAT |
9537122077 - birvank@charutarhealth.org |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| H M Patel Centre for Medical Care and Education, Karamsad |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C189||Malignant neoplasm of colon, unspecified, (2) ICD-10 Condition: K703||Alcoholic cirrhosis of liver, (3) ICD-10 Condition: K229||Disease of esophagus, unspecified, (4) ICD-10 Condition: K509||Crohns disease, unspecified, (5) ICD-10 Condition: C349||Malignant neoplasm of unspecifiedpart of bronchus or lung, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nasal Prongs |
Patient will be given oxygen via nasal prongs with FiO2 40-60% |
| Comparator Agent |
NIL |
NIL |
| Intervention |
T piece via nasopharyngeal airway |
Patient will be given oxygen through t piece via nasopharyngeal airway with FiO2 40-60% , Nasopharyngeal airway lubricated and inserted once patient reach desired level of sedation |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
All patients ASA I,II,III, IV undergoing flexible endoscopy under monitored anesthesia care |
|
| ExclusionCriteria |
| Details |
1) Patient requiring endotracheal intubation
2) Patient who have endotracheal tube insitu
3) Inadequate NBM
4) Tracheostomised patient
5) Allergy to topical anesthetics
6) Nasal deformities(deformation of nasal septum, visible distorsion or deviation from midline of nasal septum)
7) Patient on anticoagulants and with deranged coagulation profile
8)Lack of informed consent |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Hypoxia |
SPO2 less than 90 percentage for at least 15 secconds |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1) Vitals and sedation level
2) Adverse events
3)Need to insert nasopharyngeal airway in group A(nasal prongs group)
4) Patient satisfaction,Surgeons satisfaction |
Baseline, on procedure table, 5 min, 10 min, 15 min, 20 min, 25 min, 30 min, 40 min, 50 min, 60 min |
|
|
Target Sample Size
|
Total Sample Size="66" Sample Size from India="66"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
10/03/2020 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NA |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Patient will undergo pre-anesthesia workup ,written and informed consent will be taken. All patient will be kept nil by mouth 8 hrs for solid 2 hrs for clear liquid, patient with concurrent illness take medication.Preprocedural preaparation by lidocaine oral topical solution, topical pharyngeal spray with 10% lidocaine spray for upper endoscopy. Patient randomly allocated into two group using winpipe software a) nasal prongs b) t piece via nasopharyngeal airway with FiO2 between 40-60%. Patients vitals(Spo2, heart rate,respiratory rate,blood pressure) are monitored on table, every 5 mins till the end of procedure. Adverse events and correction done such as hypoxia- head tilt, chin lift,securing airway by nasopharyngeal airway, increase flow of O2 or intermittent O2 flush, bag and mask ventilation, bradycardia- fluid and vasopressor, body movement - additional dose of anesthetic drug, bleeding from nose - local pressure application, Aspiration- oral nasal suctioning interruption of procedure and securing definite airway , Ramsay sedation score will be maintained >4 during endoscopy. We focus on comparing two different methods of oxygen delivery in flexible endoscopic procedure and thereby finding out the best method of oxygen delivery for safe and efficient monitored anesthesia care for patients undergoing flexible endoscopic procedure. |